Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
Total Valuation
BioVie has a market cap or net worth of $13.67M. The enterprise value is $1.75M.
Market Cap$13.67M
Enterprise Value$1.75M
Share Statistics
BioVie has 18.45M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18.45M
Owened by Insiders9.37%
Owened by Instutions1.18%
Financial Efficiency
BioVie’s return on equity (ROE) is -2.07 and return on invested capital (ROIC) is -148.86%.
Return on Equity (ROE)-207.15%
Return on Assets (ROA)-127.42%
Return on Invested Capital (ROIC)-148.86%
Return on Capital Employed (ROCE)-202.95%
Revenue Per Employee$0
Profits Per Employee-$1,800,288
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioVie is -1.17. BioVie’s PEG ratio is 0.02.
PE Ratio-1.17
PS Ratio0.00
PB Ratio2.43
Price to Fair Value2.43
Price to FCF-1.35
Price to Operating Cash Flow-1.35
PEG Ratio0.02
Income Statement
In the last 12 months, BioVie had revenue of $0.00 and earned -$25.20M in profits. Earnings per share was -$47.26.
Revenue$0.00
Gross Profit-$229.38K
Operating Income-$23.94M
Pretax Income-$24.32M
Net Income-$25.20M
EBITDA-22.96M
Earnings Per Share (EPS)-47.26
Cash Flow
In the last 12 months, operating cash flow was -$22.02M and capital expenditures -$1.00, giving a free cash flow of -$22.02M billion.
Operating Cash Flow-$22.02M
Free Cash Flow-$22.02M
Free Cash Flow per Share-$1.19
Dividends & Yields
BioVie pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-74.16%
Earnings Yield-85.24%
Stock Price Statistics
Beta2.09
52-Week Price Change-84.18%
50-Day Moving Average1.28
200-Day Moving Average2.37
Relative Strength Index (RSI)28.65
Average Volume (3m)255.39K
Important Dates
BioVie upcoming earnings date is May 13, 2024, TBA.
Last Earnings DateFeb 14, 2024
Next Earnings DateMay 13, 2024
Ex-Dividend Date―
Financial Position
BioVie as a current ratio of 2.57, with Debt / Equity ratio of 0.39
Current Ratio2.57
Quick Ratio2.57
Debt to Market Cap0.15
Net Debt to EBITDA0.55
Interest Coverage Ratio-11.12
Taxes
In the past 12 months, BioVie has paid -$7.16M in taxes.
Income Tax-$7.16M
Effective Tax Rate0.00%
Enterprise Valuation
BioVie EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -0.71.
EV to Sales0.00
EV to EBITDA-0.62
EV to Free Cash Flow-0.71
EV to Operating Cash Flow-0.71
Balance Sheet
BioVie has $24.41M in cash and marketable securities with $382.03K in debt, giving a net cash position of -$24.02M billion.
Cash & Marketable Securities$24.41M
Total Debt$382.03K
Net Cash-$24.02M
Net Cash Per Share-$1.30
Tangible Book Value Per Share$1.63
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioVie is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside669.23%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast66.72%